Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Familial Female Mental Retardation/Epilepsy Gene Panel test is typically 14-21 business days.

What are the prerequisites for the test Familial Female Mental Retardation/Epilepsy Gene Panel

  • Referral form completed by a healthcare provider
  • Completed consent form signed by the patient or legal guardian
  • Payment information provided
  • Insurance information provided (if applicable)
  • Patient's personal and family medical history provided
  • Any relevant medical records or test results provided

What are the measure values for the test Familial Female Mental Retardation/Epilepsy Gene Panel

  • MECP2 Gene Analysis : 2-4 weeks
  • CDKL5 Gene Analysis : 2-4 weeks
  • FOXG1 Gene Analysis : 2-4 weeks
  • SCN1A Gene Analysis : 2-4 weeks
  • SLC2A1 Gene Analysis : 2-4 weeks

What does this test Familial Female Mental Retardation/Epilepsy Gene Panel identify?

  • This test identifies genetic mutations associated with mental retardation and epilepsy in females from families with a history of these conditions.
  • The panel examines a specific set of genes known to be involved in these disorders, including but not limited to:
    • CDKL5
    • ARX
    • MECP2
    • STXBP1
    • SLC9A6
    • SCN1A
    • SCN8A
  • By analyzing these genes, the test can provide information on the genetic cause of mental retardation and epilepsy in affected individuals, allowing for more accurate diagnosis and potentially guiding treatment decisions.

Why is this test Familial Female Mental Retardation/Epilepsy Gene Panel taken?

There are several reasons why the Familial Female Mental Retardation/Epilepsy Gene Panel test may be taken:

  • Diagnosis: The test can help diagnose genetic disorders that cause mental retardation and epilepsy in females.
  • Risk assessment: It can assess the risk of developing these conditions in female family members who may be at risk due to their genetic background.
  • Treatment planning: Knowing the genetic mutations present in an individual can help in developing personalized treatment plans for managing the symptoms of mental retardation and epilepsy.
  • Family planning: Understanding the genetic basis of these conditions can help individuals make informed decisions about family planning and reproductive options.

Popular FAQs on Test

The Familial Female Mental Retardation/Epilepsy Gene Panel test is a genetic test that analyzes a panel of genes associated with mental retardation and epilepsy in females. It helps identify genetic mutations that may be responsible for these conditions.
The test is recommended for females who have a family history of mental retardation or epilepsy, or individuals who have symptoms of these conditions. It can help provide a genetic diagnosis and guide treatment options.
The test is usually done using a blood sample. The sample is sent to a laboratory for analysis, where the DNA is extracted and sequenced to identify any genetic mutations in the panel of genes.
The test results can reveal if there are any genetic mutations in the panel of genes that are associated with mental retardation and epilepsy. This information can help in diagnosis, genetic counseling, and treatment planning.
The test is generally safe and non-invasive, as it only requires a blood sample. However, there may be a small risk of discomfort or bruising at the site of blood draw. It is important to discuss any concerns with a healthcare provider before undergoing the test.

Customer Google Rating